Remission Medical, a Richmond, Virginia-based virtual rheumatology company focused on expanding access to specialty care through health system partnerships, has raised Series A funding to accelerate growth, expand its clinical workforce, and scale its technology infrastructure. The investment is designed to help the company extend its embedded specialty care model to more health systems and markets across the United States.

The Series A round was led by Blue Heron Capital. The company’s funding will support expansion of its partner network, growth of its rheumatology provider team, and continued development of the infrastructure behind its virtual care model. Remission Medical has built a platform designed to help health systems address shortages in rheumatology access by integrating specialty care directly into existing healthcare operations.

Founded by Blake Wehman, Remission Medical was created to address a major healthcare challenge: limited access to rheumatology specialists. Patients with conditions such as rheumatoid arthritis, lupus, and psoriatic arthritis often face long wait times for specialist appointments, which can delay diagnosis and treatment. The company aims to reduce these barriers by providing virtual rheumatology services that work alongside health systems rather than operating as a separate consumer healthcare provider.

Remission Medical’s model is built around embedding specialty care capabilities directly into health system workflows. The company works with healthcare organizations to provide board-certified rheumatology clinicians while integrating with existing electronic medical records, scheduling systems, billing processes, and clinical operations. This approach allows health systems to expand specialty access without needing to recruit and manage large additional physician teams.

The company’s technology platform, known as RemissionOS, supports the operational side of its virtual rheumatology services. The system is designed to help coordinate appointments, clinical workflows, and patient care processes while enabling healthcare organizations to provide specialty services more efficiently. Remission Medical positions the platform as an infrastructure solution for health systems seeking to improve specialty access and patient outcomes.

The newly raised capital will help Remission Medical increase its presence among healthcare organizations and expand the availability of virtual rheumatology services. The company plans to use the funding to grow its clinical workforce, strengthen operational capabilities, and continue improving the technology that supports its care delivery model.

Investor backing from Blue Heron Capital reflects growing interest in healthcare technology companies focused on improving access, efficiency, and scalability within the healthcare system. Blue Heron Capital invests in growth-oriented companies, including businesses operating in healthcare and technology sectors.

Remission Medical’s approach comes at a time when healthcare organizations are increasingly exploring virtual care and technology-enabled services to address workforce shortages. Specialty medicine has faced persistent capacity challenges, with many patients experiencing delays in receiving expert care. Companies developing scalable models for specialty access are seeking to bridge the gap between patient demand and available clinical resources.

Unlike traditional telehealth companies that primarily connect individual patients with remote providers, Remission Medical focuses on business-to-business partnerships with health systems. The company’s embedded model allows healthcare organizations to maintain their existing patient relationships while adding additional specialty capacity.

The company has developed partnerships with healthcare organizations including Sentara, OrthoVirginia, and Ochsner Health. These collaborations demonstrate demand for models that allow health systems to expand specialty care offerings while maintaining operational alignment with their existing infrastructure.

Remission Medical’s growth also reflects broader changes in healthcare delivery, where technology is increasingly being used to improve access to specialists, reduce administrative challenges, and create more flexible care models. Virtual specialty care has gained momentum as healthcare providers look for ways to serve more patients while managing limited clinical resources.

The company’s leadership believes that improving specialty care access requires more than simply offering video appointments. Remission Medical focuses on integrating virtual rheumatology services into health system operations, allowing providers to deliver coordinated care while helping organizations retain patients who might otherwise face long delays or seek care elsewhere.

With Series A investment from Blue Heron Capital, Remission Medical is positioned to expand its virtual rheumatology platform and strengthen its role as a healthcare infrastructure partner. The company aims to continue building technology and clinical capabilities that help health systems deliver faster, more accessible specialty care to patients across the country.

Related Articles